a parallel, randomised, open-label clinical trial evaluating the safety and efficacy of methotrexate with apremilast in patients with moderate to severe palmoplantar psoriasis. (2021). International Journal of Pharmacetical Sciences Letters, 11(2), 1-11. https://ijpsl.org/index.php/ijpls/article/view/21